Collaborative research led by investigators at Dana-Farber/Boston Children's Cancer and Blood Disorders Center defines a ...

Analysts at Precedence Research expect the gene-editing market to grow 15.7% annually and reach $40.1 billion by 2034, creating some tremendous long-term opportunities for investors. Here are seven of ...

Knocking out a single gene reprograms part of the large intestine to function like the nutrient-absorbing small intestine. In ...

At meeting on human embryo editing, CRISPR pioneer says science is a long way from knowing if germline DNA can be safely ...

Transgenic animals continue to play an essential role in many aspects of zebrafish research, including the development of disease models. The most widely used system for zebrafish transgenesis is the ...

Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in three years. The company is targeting oncology and rare ...

Scientists at the University of California, Santa Cruz (UCSC), used CRISPR to engineer cellular models of embryos that mimic what happens in the first few days after reproductive cells meet.

Bharat Biotech on Thursday launched vertically integrated cell and gene therapy, viral production facility at Genome Valley in Hyderabad. The company has invested around $75 million, which it says ...

Meanwhile, CRISPR Therapeutics is working to advance several other gene-editing programs. The company's pipeline includes two allogeneic chimeric antigen receptor T cell (CAR-T) therapies in ...

With these powerful tool strains, Chen's lab was able to induce and track changes in a variety of immune system cells in response to gene editing, and to fine-tune sets of genes in different ...